Drug Shortage Report for TARO-QUETIAPINE
| Report ID | 116295 |
| Drug Identification Number | 02397110 |
| Brand name | RAN-QUETIAPINE |
| Common or Proper name | QUETIAPINE |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | QUETIAPINE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N05AH |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-06-01 |
| Estimated end date | Unknown |
| Actual end date | 2020-06-22 |
| Shortage status | Resolved |
| Updated date | 2020-08-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-08-28 | French | Compare |
| v4 | 2020-08-28 | English | Compare |
| v3 | 2020-06-02 | English | Compare |
| v2 | 2020-06-01 | French | Compare |
| v1 | 2020-06-01 | English | Compare |
Showing 1 to 5 of 5